Luigi Notari

Senior Scientist Neoantigen Production & Development NeoGap Therapeutics

Ph.D. in Biochemistry and Molecular Biology with several years of international experience in relevant fields. With Neogap Therapeutics for 8 years, where my experience in protein expression, purification and in surface chemistry was used to develop our current EpiTCer technology platform as a key raw material for the production of pTTL.

Seminars

Thursday 23rd July 2026
A First-in-Human Phase I/IIa Trial of Personalised Tumour-Trained Lymphocytes (pTTL) Derived From Regional Lymph Nodes for the Treatment of Colorectal Cancer
3:00 pm
  • Personalised Neoantigen-based cell therapy for solid tumours
  • First in human trial NEOGAP-CRC-01
  • Safety and early biomarkers data
Luigi Notari
View all Speakers
View Event Brochure